28302862 35489781 35982797 35211768 29487132 34411560 30914442 33484816 33651366 27801563 - Search Results

Year	Number of Results
2016	1
2017	2
2018	1
2019	1
2021	3
2022	3
2023	0

1

Arresting the Development of Addiction: The Role of β-Arrestin 2 in Drug Abuse.

Porter-Stransky KA, Weinshenker D. Porter-Stransky KA, et al. J Pharmacol Exp Ther. 2017 Jun;361(3):341-348. doi: 10.1124/jpet.117.240622. Epub 2017 Mar 16. J Pharmacol Exp Ther. 2017. PMID: 28302862 Free PMC article. Review.

2

Role of Efficacy as a Determinant of Locomotor Activation by Mu Opioid Receptor Ligands in Female and Male Mice.

Santos EJ, Banks ML, Negus SS. Santos EJ, et al. J Pharmacol Exp Ther. 2022 Jul;382(1):44-53. doi: 10.1124/jpet.121.001045. Epub 2022 Apr 30. J Pharmacol Exp Ther. 2022. PMID: 35489781

3

Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine.

Aslanoglou D, Bertera S, Friggeri L, Sánchez-Soto M, Lee J, Xue X, Logan RW, Lane JR, Yechoor VK, McCormick PJ, Meiler J, Free RB, Sibley DR, Bottino R, Freyberg Z. Aslanoglou D, et al. iScience. 2022 Jul 19;25(8):104771. doi: 10.1016/j.isci.2022.104771. eCollection 2022 Aug 19. iScience. 2022. PMID: 35982797 Free PMC article.

4

Opioid-like adverse effects of tianeptine in male rats and mice.

Baird TR, Akbarali HI, Dewey WL, Elder H, Kang M, Marsh SA, Peace MR, Poklis JL, Santos EJ, Negus SS. Baird TR, et al. Psychopharmacology (Berl). 2022 Jul;239(7):2187-2199. doi: 10.1007/s00213-022-06093-w. Epub 2022 Feb 24. Psychopharmacology (Berl). 2022. PMID: 35211768

5

The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation.

Pack TF, Orlen MI, Ray C, Peterson SM, Caron MG. Pack TF, et al. J Biol Chem. 2018 Apr 20;293(16):6161-6171. doi: 10.1074/jbc.RA117.001300. Epub 2018 Feb 27. J Biol Chem. 2018. PMID: 29487132 Free PMC article.

6

A systems omics-based approach to decode substance use disorders and neuroadaptations.

Veerappa A, Pendyala G, Guda C. Veerappa A, et al. Neurosci Biobehav Rev. 2021 Nov;130:61-80. doi: 10.1016/j.neubiorev.2021.08.016. Epub 2021 Aug 17. Neurosci Biobehav Rev. 2021. PMID: 34411560 Free PMC article. Review.

7

Biased Receptor Signaling in Drug Discovery.

Kenakin T. Kenakin T. Pharmacol Rev. 2019 Apr;71(2):267-315. doi: 10.1124/pr.118.016790. Pharmacol Rev. 2019. PMID: 30914442 Review.

8

Prolonged dopamine D₃ receptor stimulation promotes dopamine transporter ubiquitination and degradation through a PKC-dependent mechanism.

Luis-Ravelo D, Fumagallo-Reading F, Castro-Hernandez J, Barroso-Chinea P, Afonso-Oramas D, Febles-Casquero A, Cruz-Muros I, Salas-Hernandez J, Mesa-Infante V, Rodriguez-Nuñez J, Gonzalez-Hernandez T. Luis-Ravelo D, et al. Pharmacol Res. 2021 Mar;165:105434. doi: 10.1016/j.phrs.2021.105434. Epub 2021 Jan 20. Pharmacol Res. 2021. PMID: 33484816

9

Targeting β-Arrestins in the Treatment of Psychiatric and Neurological Disorders.

Harris SS, Urs NM. Harris SS, et al. CNS Drugs. 2021 Mar;35(3):253-264. doi: 10.1007/s40263-021-00796-y. Epub 2021 Mar 2. CNS Drugs. 2021. PMID: 33651366 Review.

10

Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor Agonists.

Xu W, Wang X, Tocker AM, Huang P, Reith ME, Liu-Chen LY, Smith AB 3rd, Kortagere S. Xu W, et al. ACS Chem Neurosci. 2017 Mar 15;8(3):486-500. doi: 10.1021/acschemneuro.6b00221. Epub 2016 Nov 23. ACS Chem Neurosci. 2017. PMID: 27801563 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results